weight loss

WeightWatchers' acquisition of a telehealth company is just the latest commercial push into the market for a new generation of medications that promise significant weight loss.

The company is tapping into a red-hot market for drugs that address obesity with the purchase of telehealth operator Sequence, which can prescribe medications such as Ozempic, Wegovy and Trulicity.

The platform banned food advertising, yet many videos viewed by millions of kids continue to showcase candy, soda and packaged snacks, likely affecting kids' food preferences, researchers say.

The national study found a small but significant decline in the average BMI of more than 14,000 schoolkids after implementation of a 2010 federal law that boosted nutrition standards for school meals.

Many eating disorder specialists oppose the new guidance's focus on weight loss and BMI, and say it minimizes the risk of disordered eating and will perpetuate deep-rooted, damaging stigmas.

The new weight-loss drugs can be life-changing for people facing health conditions worsened by obesity, but price and spotty insurance coverage may keep them out of reach.

In her new book You Just Need To Lose Weight and 19 Other Myths About Fat People, Aubrey Gordon tackles the biases and myths that she says keep fat people on the margins of society.

A new wave of obesity care startups offer access to new weight loss medications. But do they offer good health care?

People now have at their disposal more medicines that are effective at reducing weight, but none can counter obesity alone. One big problem: Insurance coverage remains spotty, and the costly drugs may be needed long term.

The body mass index — a simple mathematical equation — is tied to a measure of obesity invented almost 200 years ago. On the downside, it can stand between patients and treatment for weight issues. It particularly mismeasures Black women and Asians.